Register Login

All Posts

Acquired Hemophilia, rpVIII, and Bethesda Titer

Here is a 12-2-23 email from Hrvoje Melinšćak MD, Consultant in Haematology, the Warren Alpert Medical School of Brown University, Rhode Island Hospital/The Miriam Hospital. I would enquire regarding rpFVIII’s impact on inhibitor titre assessment through the Bethesda assay in a case regarding acquired haemophilia A. Does significant background rpFVIII (Obizur) concentrate lend to significant […]
read more

Readily Measurable Products of SARS-Cov-2 Endothelial Cell Injury

This is the second in a series of discussions about the relationship between hemostasis and inflammation. These discussions were part of our Rutgers CLSC 5124 Advanced Hemostasis course that features answers provided by our participants. List the readily measurable products of SARS-Cov-2 mediated endothelial cell injury. SARS-CoV-2 is increasingly being recognized as a disease of […]
read more